The possible role of copper ions in atherogenesis: The Blue Janus

Atherosclerosis

Volumn 133, Issue 2, 1997, Pages 139-152

  Ferns, Gordon A A ^a,b   Lamb, David J ^a   Taylor, Andrew ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Copper ions; Endothelium; Low density lipoprotein; Macrophage; Smooth muscle

Indexed keywords

CERULOPLASMIN; COLLAGEN; COPPER ION; LOW DENSITY LIPOPROTEIN; PROTEIN LYSINE 6 OXIDASE; SCLEROPROTEIN; SUPEROXIDE DISMUTASE;

ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; COLLAGEN SYNTHESIS; COPPER METABOLISM; EXTRACELLULAR MATRIX; INTIMA; LIPOPROTEIN METABOLISM; MACROPHAGE; OXIDATION; PRIORITY JOURNAL; SMOOTH MUSCLE;

ARTERIOSCLEROSIS; COPPER; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION;

EID: 0030867360     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00130-5     Document Type: Article

References (219)

1. Linder MC. (1991) Nutrition and metabolism of the trace elements. In: Linder, editor. Nutritional Biochemistry and Metabolism, Elsevier, Amsterdam.
2. Van Campen D.R., Scaife P.U. Zinc interference with copper absorption in rats. J Nutr. 91:1967;473-476.
3. Reiser S., Ferretti R.J., Fields M., Smith J.C. Role of dietary fructose in the enhancement of mortality and biochemical changes associated with copper deficiency in rats. Am J Clin Nutr. 38:1983;214-222.
4. Reiser S., Smith J.C., Mertz W.et al. Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am J Clin Nutr. 42:1985;242-251.
5. Fields M., Holbrook J., Scholfield D., Rose A., Smith J.C., Reiser S. Development of copper deficiency in rats fed fructose or starch: weekly measurements of copper indices in blood. Proc Soc Exp Biol Med. 181:1986;120-124.
6. Van Campen D.R., Gross E. Influence of ascorbic acid on the absorption of copper by rats. J Nutr. 95:1968;617-622.
7. Smith C.H., Bidlack W.K. Interrelationship of dietary ascorbic acid and iron on the tissue distribution of ascorbic acid, iron and copper in female guinea pigs. J Nutr. 110:1980;1398-1408.
8. Cohen D.I., Illowsky B., Linder M.C. Altered copper absorption in tumor-bearing and estrogen-treated rats. Am J Physiol. 263:1979;E309-E315.
9. Johnson P.E., Milne D.B., Lykken G.I. Effects of age and sex on copper absorption, biological half-life and status in humans. Am J Clin Nutr. 56:1992;917-925.
10. Milne D.B., Johnson P.E. Assessment of copper status: effect of age and gender on reference ranges in healthy adults. Clin Chem. 39:1993;883-887.
11. Cordano A., Baertl J.M., Graham G.G. Copper deficiency in infancy. Pediatrics. 26:1966;326.
12. Al-Rushid R.A., Spangler J. Neonatal copper deficiency. N Engl J Med. 285:1971;841-846.
13. Hartz J.W., Funakoshi S., Deutsch H.F. The levels of superoxide dismutase and catalase in human tissues as determined immunochemically. Clin Chim Acta. 46:1973;125-131.
14. Owen L.A. The response of serum ceruloplasmin to injections of Walker 256 tumor-cells or turpentine into rats. Biol Trace Elem Res. 3:1981;217-224.
15. Herve M., Garnier A., Tosi L., Steinbuch M. Spectroscopic and photo-reduction studies of copper chromophores in ceruloplasmin. Eur J Biochem. 116:1981;177-183.
16. Goldstein I.M., Kaplan H.B., Edelson H.S., Weissmann G. Ceruloplasmin: a scavenger of superoxide anion radicals. J Biol Chem. 254:1975;4040-4045.
17. Fox P.L., Mukhopadhyay C., Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci. 56:1995;1749-1758.
18. Kagan H.M. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol Res Pract. 190:1994;910-919.
19. Abel-Mageed A.B., Welti R., Oehme F.W., Pickrell J.A. Perinatal hypocuprosis affects synthesis and composition of neonatal lung collagen, elastin and surfactant. Am J Physiol. 267:1994;L679-L685.
20. Dalessandri K.M., Eisele P., Wong T.S., Parker J., Rucker R.B. Elastin degradation in the aorta of Watanabe hereditary hyperlipidemic rabbits. Mech Ageing Dev. 74:1994;117-120.
21. Hamalainen E.R., Kemppainen R., Pihlajaniemi T., Kivirikko K.I. Structure of the human lysyl oxidase gene. Genomics. 17:1993;544-548.
22. Mariani T.J., Trackman P.C., Kagan H.M.et al. The complete derived amino acid sequence of human lysyl oxidase and assignment of the gene to chromosome 5 (extensive homology to murine ras recision gene). Matrix. 12:1992;242-248.
23. Sommer P., Gleyzal C., Raccurt M.et al. Transient expression of lysyl oxidase by liver myofibroblasts in murine schistosomiasis. Lab Invest. 69:1993;460-470.
24. Menkes J.H., Alter M., Steigkder G.K., Weakley D.R., Sung J.H. A sex-linked recessive disorder with retardation of growth, peculiar hair and focal cerebral and cerebellar degeneration. Pediatrics. 29:1962;764-797.
25. Danks D.M., Campbell P.E., Stevens B.J., Mayne V., Cartwright E. Menkes' kinky hair syndrome: an inherited defect in copper absorption with widespread effects. Pediatrics. 50:1972;188-201.
26. Tanzi R.E., Petrukin K., Chernov I., Pellequer J.L., Wasco W., Ross B. The Wilson's disease gene is a copper transporting ATPase with homology to the Menkes' disease gene. Nat Genet. 519:19;344-350.
27. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., Cox D.W. The Wilson's disease gene is a putative copper transporting P-type ATPase similar to Menkes' gene. Nat Genet. 5:1993;327-333.
28. Wu J., Forbes J.R., Chen H.S., Cox D.W. The LEC rat has a deletion in the copper transporting ATPase gene. Nat Genet. 7:1994;541-545.
29. Klevay L.M. Coronary heart disease. The zinc/copper hypothesis. Am J Clin Nutr. 28:1975;764-774.
30. Klevay L.M. Elements of ischaemic heart disease. Perspect Biol Med. 20:1977;186-192.
31. Klevay L.M. Interactions of copper and zinc in cardiovascular disease. Ann New York Acad Sci. 355:1980;140-151.
32. Klevay L.M. The influence of copper and zinc on the occurrence of ischaemic heart disease. J Environ Pathol Toxicol. 4:1980;281-287.
33. Klevay LM. Ischaemic heart disease: Updating the zinc/copper hypothesis. In: Naito HK, editor. Nutrition and Heart Disease (Monographs of the American College of Nutrition. vol. 5. New York: S.P. Medical and Scientific Books, 1987:61-67.
34. Klevay L.M., Inman L., Johnson L.K.et al. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism. 33:1984;1112-1118.
35. Klevay L.M. Dietary copper: a powerful determinant of cholesterolaemia. Med Hypothesis. 24:1987;111-119.
36. Food and Nutrition Board Recommended Dietary Allowances. 8th edn. Washington D.C.: National Reasearch Council, National Academy of Sciences, 1974:95-96.
37. Brown E.D., Howard M.P., Smith Jr J.C. The copper content of regular, vegetarian and renal diets. Fed Proc Fed Am Soc Exp Biol. 36:1977;1122.
38. Klevay L.M., Reck S.J., Barcome D.F. Evidence of dietary copper and zinc deficiencies. JAMA. 241:1979;1916-1918.
39. Gormican A. Inorganic elements in foods used in hospital menus. J Am Dietet Assoc. 56:1970;397-403.
40. Milne D.B., Schnakenberg D.D., Johnson H.L., Kuhl G.L. Trace mineral intake of enlisted military personnel. J Am Dietet Assoc. 76:1980;41-45.
41. Murphy EW, Watt BK, Page L. Regional variations in vitamin and trace element content of Type A school lunches. In: Hemphill D, editor. Trace Elements in Environmental Health. IV. Columbia, MO: University of Missouri, 1971.
42. White H.S. Inorganic elements in weighed diets of girls and young women. J Am Dietet Assoc. 55:1969;38-43.
43. Guthrie B.E., Robinson M.F. Daily intakes of manganese, copper, zinc, and cadmium by New Zealand women. Br J Nutr. 38:1977;55-63.
44. Klevay L.M. Reply to: Fischer PWF, Collins MW. Relationship between serum zinc and copper and risk factors associated with cardiovascular disease. Am J Clin Nutr. 34:1981;81.
45. Kannel W.B., Castelli W.P., Gordon T., McNamara P.M. Serum cholesterol lipoproteins and risk of coronary heart disease The Framingham Study. Ann Intern Med. 74:1971;1-12.
46. Miller G.J., Miller N.E. Plasma high density lipoprotein concentration and the development of ischaemic heart disease. Lancet. 1:1975;16-18.
47. Schaffner T., Taylor K., Batrucci E.J.et al. Arterial foam-cells with distinctive immunomorphologic and histochemical features of macrophages. Am J Pathol. 100:1980;57-80.
48. Allen K.G.D., Klevay L.M. Hyperlipoproteinaemia in rats due to copper deficiency. Nutr Rep Int. 22:1980;295-299.
49. Lefevre M., Keen C.L., Lonnerdal B., Hurley L.S., Scheeman B.O. Copper deficiency-induced hypercholesterolaemia: effects on HDL subfractions and hepatic lipoprotein receptor activity in the rat. J Nutr. 116:1986;1735-1746.
50. Carr T.P., Lei K.Y. High density lipoprotein cholesterol ester and protein catabolism in hypercholesterolemic rats induced by copper deficiency. Metabolism. 39:1990;518-524.
51. Lau B.W.C., Klevay L.M. Post heparin lipoprotein lipase in copper deficient rats. J Nutr. 112:1982;928-933.
52. Carr T.P., Lei K.Y. In vivo apoprotein catabolism of high density lipoproteins in copper-deficient, hypercholesterolaemic rats. Proc Soc Exp Biol Med. 191:1989;370-376.
53. 14C)mevalonate into cholesterol, lanosterol and squalene in copper deficient rats. J Nutr. 110:1980;859-867.
54. Nassir F., Mazur A., Gueux E., Serougne C., Rayssiguier Y. Apolipoprotein AI, AIV and E synthesis in the liver of copper deficient rats. Lipids. 29:1994;727-729.
55. Harvey P.W., Allen K.G.D. Decreased plasma lecithin: cholesterol acyl transferase in copper deficient rats. J Nutr. 112:1981;928-933.
56. Allen K.G.D., Klevay L.M. Copper deficiency and cholesterol metabolism in the rat. Atherosclerosis. 31:1978;259-271.
57. Al-Othman A.A., Rosenstein F., Lei K.Y. Copper deficiency alters plasma pool size, percent composition and concentration of lipoprotein components in rats. J Nutr. 122:1992;1199-1204.
58. Nassir F., Mazur A., Serougne C., Gueux E., Rayssiguier Y. Hepatic apolipoprotein B synthesis in copper deficient rats. FEBS Lett. 322:1993;33-36.
59. Lei K.Y. Cholesterol metabolism in copper deficient rats. Nutr Rep Int. 15:1977;597-605.
60. Yount N.Y., McNamara D.J., Al-Othman A.A., Lei K.Y. The effects of copper deficiency on rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity. J Nutr Biochem. 1:1990;27-33.
61. Freeland-Graves J.H., Han W.-H., Friedman B.J., Shorey R.L. Effect of dietary zinc to copper ratios on cholesterol and high density lipoprotein-cholesterol levels in women. Nutr Rep Int. 22:1980;285-294.
62. He J., Tell G.S., Tang Y-C., Mo P-S., He G-Q. Relation of serum zinc and copper to lipids and lipoproteins: the Yi People Study. J Am Coll Nutr. 11:1992;74-78.
63. Laitinen R., Vuori E., Viikari J. Serum zinc and copper: associations with cholesterol and triglyceride levels in children and adolescents. Cardiovascular risk in young Finns. J Am Coll Nutr. 8:1989;400-406.
64. Kromhout D., Wibowo A.A.E., Herber R.F.M.et al. Trace metals and coronary heart risk indicators in 152 elderly men (the Zutphen Study). Am J Epidemiol. 122:1985;378-385.
65. Chappuis P, Jacqueson A, Ducemetiere P, Rousselet F. Magnesium, copper and zinc: relationships with ischemic heart disease risk factors. In: Halpern S, Durlach J, editors. Magnesium Deficiency. Karger, Basel, Switzerland 1985:142-145.
66. Fischer P.W.F., Collins M.W. Relationship between serum zinc and copper and risk factors associated with cardiovascular disease. Am J Clin Nutr. 34:1981;595-597.
67. Iskra M., Patelski J., Majewski W. Concentrations of calcium, magnesium, zinc, and copper in relation to free fatty acids and cholesterol in serum of atherosclerotic men. J Trace Elem Electrolytes Health Dis. 7:1993;185-188.
68. Magalova T., Brtkova A., Bederova A., Kajaba I., Puchonova I. Serum copper and zinc in industrial centres in Slovakia. Biol Trace Elem Res. 40:1994;225-235.
69. Reiser S., Powell A., Yang C., Canary J.J. Effect of copper intake on blood cholesterol and its lipoprotein distribution in men. Nutr Rep Int. 36:1987;641-649.
70. Goldstein J.L., Anderson R.G.W., Brown M.S. Coated pits, coated vesicles and receptor-mediated endocytosis. Nature. 279:1979;679-685.
71. St Clair R.W., Leight M.A. Differential effects of isolated lipoproteins from normal and hypercholesterolaemic rhesus monkeys on cholesterol esterification and accumulation in arterial smooth muscle cells in culture. Biochim Biophys Acta. 530:1978;279-291.
72. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA. 76:1979;333-337.
73. Brown M.S., Ho Y.K., Goldstein J.L. The cholesterol ester cycle on macrophage foam cells. J Biol Chem. 255:1980;9344-9352.
74. Fogelman A.M., Shechter I., Seager J., Hokom M., Child J.S., Edwards P.A. Malondialdehyde alteration of low density lipoprotein leads to cholesterol accumulation in human monocyte-derived macrophages. Proc Natl Acad Sci USA. 77:1980;2214-2218.
75. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 81:1984;3883-3887.
76. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature. 343:1990;531-535.
77. Stanton L.W., White R.T., Bryant C.M., Protter A.A., Endemann G. A macrophage Fc receptor for IgG is also a receptor for oxidised LDL. J Biol Chem. 267:1992;22446-22451.
78. Endemann G., Staton L.W., Madden K.S., Bryant C.M., White R.T., Protter A.A. CD36 receptor for oxidized low density lipoprotein. J Biol Chem. 268:1993;11811-11816.
79. Ramprasad M.P., Fischer W., Witztum J.L., Sambrano G.R., Quehenberger O., Steinberg D. The 94- to 97-kDa mouse macrophage membrane protein that recognises oxidised low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA. 92:1995;9580-9584.
80. Henriksen T., Mahoney E.M., Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoprotein. Proc Natl Acad Sci USA. 78:1981;6499-6503.
81. Henriksen T., Mahoney E.M., Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 3:1983;149-159.
82. Cathcart M.K., Morel D.W., Chisolm G.M. Monocytes and neutrophils oxidise low density lipoprotein making it cytotoxic. J Leukocyte Biol. 38:1985;341-350.
83. Hiramatsu K., Rosen H., Heinecke J.W., Wolfbauer G., Chait A. Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis. 7:1987;55-60.
84. Jialal I., Grundy S.M. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest. 87:1991;597-601.
85. Lamb D.J., Wilkins G.M., Leake D.S. The oxidative modification of low density lipoprotein by human lymphocytes. Atherosclerosis. 92:1992;187-192.
86. Jurgens G., Lang J., Esterbauer H., Holasek A. Modification of human LDL by 4-hydroxynonenal. IRCS Biochem. 12:1984;252-253.
87. Jessup W., Jurgens G., Lang J., Esterbauer H., Dean R.T. The interaction of 4-hydroxynonenol-modified LDL with the fibroblast apo B/E receptor. Biochem J. 234:1986;245-248.
88. Fruebis J., Parthasarathy S., Steinberg D. Evidence for a concerted reaction between lipid hydroperoxides and polypeptides. Proc Natl Acad Sci USA. 89:1992;10588-15092.
89. Haberland M.E., Fong D., Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe hyperlipidemic (WHHL) rabbits. Science. 241:1988;215-218.
90. Palinski W., Rosenfeld M.E., Ylä-Hertuala S. LDL undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 86:1989;1372-1376.
91. Ylä-Herttuala S., Palinski W., Rosenfeld M.E.et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 84:1989;1086-1093.
92. Wojcicki J.L., Rozewicka B., Barcew-Wiszniewska L.et al. Effect of selenium and vitamin E on the development of experimental atherosclerosi in rabbits. Atherosclerosis. 87:1991;9-19.
93. Verlangieri A.J., Bush M.J. Effects of d-α-tocopherol supplementation on experimentatlly induced primate atherosclerosis. J Am Coll Nutr. 11:1992;131-138.
94. Bjökhem I., Henriksson-Freyschuss A., Breuer O., Diczfalusy U., Berglund L., Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb. 11:1991;15-22.
95. Kita T., Nagano Y., Yokode M.et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolaemia. Proc Natl Acad Sci USA. 84:1987;5928-5931.
96. Carew T.E., Schwenke D.C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolaemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich and fatty streaks and slow progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA. 84:1987;7725-7729.
97. Nagano Y., Nakamura T., Matsuzawa Y., Cho M., Yeda Y., Kita T. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit-long term antiatherogenic effect and effects on established plaques. Atherosclerosis. 92:1992;131-140.
98. Uchida K., Toyokuni S., Nishikawa K.et al. Michael addition-type-4-hydroxy-2-nonenal adducts in modified low density lipoproteins: markers for atherosclerosis. Biochem. 33:1994;12487-12494.
99. Parums D.V., Brown D.L., Mitchinson M.J. Serum antibodies to oxidise low density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med. 114:1990;383-387.
100. Salonen J.T., Ylä-Herttuala S., Yamamoto S.et al. Autoantibodies against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883-887.
101. Ylä-Herttuala S., Palinski W., Butler S.W., Picard S., Steinberg D., Witzum J.L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb. 14:1994;32-40.
102. Klimov A.N. In vivo formation of modified lipoproteins with increased affinity for macrophages. Atheroscler Rev. 17:1988;75-86.
103. Ehrenwald E., Chisolm G.M., Fox P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest. 93:1994;1493-1501.
104. Lamb D.J., Leake D.S. Acidic pH enables caeruloplasmin to catalyse the modification of low density lipoprotein. FEBS Lett. 338:1994;122-126.
105. Swain J.A., Darley-Usmar V., Gutteridge J.M. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett. 342:1994;49-52.
106. Kuzuya M., Yamada K., Hayashi T.et al. Role of lipoprotein-copper complex in copper catalyzed peroxidation of low density lipoprotein. Biochim Biophys Acta. 1123:1992;334-341.
107. Witztum J.L., Mahoney E.M., Branks M.J., Fisher M., Elam R., Steinberg D. Non-enzymatic glycation of LDL alters its biologic activity. Diabetes. 31:1982;283-291.
108. Kobayashi K., Watanabe J., Umeda F., Nawata H. Glycation accelerates the oxidation of low density lipoprotein by copper ions. Endocrine J. 42:1995;461-465.
109. Albrink M.J., Lavietes P.H., Mann E.B. Vascular disease and serum lipids in diabetes mellitus; observations of 30 years (1931-1961). Ann Intern Med. 58:1963;305-323.
110. Burkitt M.J., Milne L. Hydroxyl radical formation from Cu(II)-trolox mixtures: insights into the pro-oxidant properties of alpha-tocopherol. FEBS Lett. 379:1996;51-54.
111. Berliner J.A., Territo M.C., Sevanian A.et al. Minimally modified LDL stimulates monocyte endothelial actions. J Clin Invest. 85:1990;1260-1266.
112. Cushing S.D., Berliner A., Valente A.J.et al. Minimally modified LDL induces MCP-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci, USA. 87:1990;5134-5138.
113. Weiss J.R., Pitas R.E., Wilson B.D., Rodgers G.M. Oxidised low density lipoprotein increases cultured human endothelial cell tissue factor activity and reduces protein C activation. FASEB J. 5:1991;2459-2465.
114. Drake T.A., Hannani K., Fei H.H., Lavi S., Berliner J.A. Minimally oxidised low density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am J Path. 138:1991;601-607.
115. Rajavashisth T.B., Andalibi A., Territo M.C.et al. Induction of endothelial cell expression of granulocyte and macrophage CSFs by modified LDL. Nature. 344:1990;254-257.
116. Galle J., Mulsch A., Busse R., Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb. 11:1991;198-203.
117. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidised low density lipoprotein inhibits relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 83:1991;2012-2020.
118. Salmon S., Maziere C., Auclair M., Theron L., Santus R., Maziere J.C. Malondialdehyde modification and copper-induced auto-oxidation of high density lipoprotein decreases cholesterol efflux from human cultured fibroblasts. Biochim Biophys Acta. 1125:1992;230-235.
119. Rifici V.A., Khachadurian A.K. Oxidation of high density lipoproteins; characterization and effects on cholesterol efflux from J774 macrophages. Biochim Biophys Acta. 1299:1996;87-94.
120. Lynch S.M., Frei B. Mechanisms of copper and iron dependent oxidative modification of human low density lipoprotein. J Lipid Res. 34:1993;1745-1753.
121. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest. 74:1984;1890-1894.
122. Heinecke J.W., Baker H., Rosen H., Chait A. Superoxide-mediated modification of low density lipoprotein by human arterial smooth muscle cells. J Clin Invest. 77:1989;757-761.
123. Wilkins G.M., Leake D.S. Free radicals and low density lipoprotein oxidation by macrophages. Biochem Soc Trans. 18:1990;1170-1171.
124. Jessup W., Simpson J.A., Dean R.T. Does superoxide have a role in macrophage-mediated oxidative modification of LDL? Atherosclerosis. 99:1993;107-120.
125. Smith J.B., Cusumano J.C., Babbs C.F. Quantitative effects of iron chelators on hydroxyl radical production by superoxide driven Fenton reaction. Free Radic Res Commun. 8:1990;101-106.
126. Bedwell S., Dean R.T., Jessup W. The action of defined oxygen centred free radicals on human low density lipoprotein. Biochem J. 262:1989;707-712.
127. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem. 262:1987;10098-10103.
128. Sparrow C.P., Olszewski J. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J Lipid Res. 34:1993;1219-1228.
129. Graham A., Wood J.L., O'Leary V.J., Stone D. Human (THP-1) macrophages oxidise LDL by a thiol-dependent mechanism. Free Radic Res. 21:1994;295-308.
130. Lamb D.J., Rees E., Leake D.S. The oxidation of LDL by thiols depends on the thiol chain length and charge. Atherosclerosis. 100:1994;44.
131. Kritharides L., Jessup W., Dean R.T. Macrophages require both iron and copper to oxidize low density lipoprotein in Hank's balanced salt solution. Arch Biochem Biophys. 323:1995;127-132.
132. Sparrow C.P., Parthasarathy S., Steinberg D. Enzymatic modification of low density lipoprotein by purified lipooxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res. 29:1988;745-753.
133. Parathasarathy S., Weiland E., Steinberg D. A role of endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci USA. 86:1989;1046-1050.
134. Rankin S.M., Parthasarathy S., Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res. 32:1991;449-456.
135. Sparrow C.P., Olszewski J. Cellular oxidative modification of low density lipoprotein does not require lipoxygenases. Proc Natl Acad Sci USA. 89:1992;128-131.
136. Folcik V.A., Cathcart M.K. Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation. J Lipid Res. 34:1993;69-79.
137. Thomas C.E., Jackson R.L. Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins. J Pharmacol Exp Ther. 256:1991;1182-1188.
138. O'Leary V.J., Darley-Usmar V.M., Russell L.J., Stone D. Pro-oxidant effects of lipoxygenase derived peroxides on the copper-initiated oxidation of low density lipoprotein. Biochem J. 282:1992;631-634.
139. 2+ stimulated oxidation of low density lipoprotein. Arch Biochem Biophys. 315:1994;244-254.
140. Noguchi N., Gotoh N., Niki E. Effects of ebselen and probucol on oxidative modification of lipid and protein of low density lipoprotein induced by free radicals. Biochim Biophys Acta. 1213:1994;176-182.
141. 1H-NMR spectroscopy. Biochim Biophys Acta. 1256:1995;130-140.
142. Bowry V.W., Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low density lipoprotein. Am Chem Soc. 115:1993;6029-6044.
143. Ingold K.U., Bowry V.W., Stocker R., Walling C. Auto-oxidation of lipids and auto-oxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersion of lipids: unrecognised consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci USA. 90:1993;45-49.
144. Maiorino M., Zamburlini A., Roveri A., Ursini F. Pro-oxidant role of vitamin E in copper induced lipid peroxidation. FEBS Lett. 330:1993;174-176.
145. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation in oxidative modification of LDL. Free Radic Biol Med. 13:1992;341-390.
146. Lynch S.M., Frei B. Reduction of copper, but not iron, by human low density lipoprotein (LDL). Implications for metal ion-dependent oxidative modification of LDL. J Biol Chem. 270:1995;5158-5163.
147. Smith C., Mitchinson M.J., Aruoma O.I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem J. 286:1992;901-905.
148. Swain J., Gutteridge J.M. Pro-oxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett. 368:1995;513-515.
149. Lamb D.J., Mitchison M.J., Leake D.S. Transitional metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Lett. 374:1995;12-16.
150. Evans P.J., Smith C., Mitchison M.J., Halliwell B. Metal ion release from mechanically-disrupted human arterial wall. Implications for the development of atherosclerosis. Free Radic Res. 23:1995;465-469.
151. Hunt J.V., Bottoms M.A., Mitchison M.J. Ascorbic acid oxidation: a potential cause of the elevated severity of atherosclerosis in diabetes mellitus. FEBS Lett. 311:1992;161-164.
152. Newberne P.M., Hunt C.E., Young V.R. The role of diet and the reticuloendothelium system in the response of rats to salmonella typhimurium infection. Br J Exp Pathol. 49:1968;448-456.
153. Graham G.G., Cordano A. Copper depletion and deficiency in the malnourished infant. Johns Hopkins Med J. 124:1969;139-150.
154. Bala S., Failla M.L. Copper deficiency reversibly impairs DNA synthesis in activated T lymphocytes by limiting interleukin-2 activity. Proc Natl Acad Sci USA. 89:1992;6794-6797.
155. Hopkins R.G., Failla M.L. Chronic intake of a marginally low copper diet impairs in vitro activities of lymphocytes and neutrophils from male rats despite minimal impact on conventional indicators of copper status. J Nutr. 125:1995;2658-2668.
156. Kelley D.S., Daudu P.A., Taylor P.C., Mackey B.E., Turnlund J.R. Effects of low copper diets on human immune response. Am J Clin Nutr. 62:1995;412-416.
157. Pocino M., Baute L., Malave I. Influence of the oral administration of excess copper on the immune response. Fundam Appl Toxicol. 16:1991;249-256.
158. Windhauser M.M., Kappel L.C., McClure J., Hegsted M. Suboptimal levels of dietary copper vary immunosuppressiveness in rats. Biol Trace Elem Res. 30:1991;205-217.
159. Bala S., Lunney J.K., Failla M.L. Effects of copper deficiency on T-cell mitogenic responsiveness and phenotypic profile of blood mononuclear cells from swine. Am J Vet Res. 53:1992;1231-1235.
160. Licastro F., Morini M.C., Chiricolo M.et al. Plasmic trace elements and immune function in healthy elderly. J Trace Elem Electrolytes Health Dis. 7:1993;234-236.
161. Bala S., Failla M.L., Lunney J.K. Alterations in splenic lymphoid cell subsets and activation antigens in copper-deficient rats. J Nutr. 121:1991;745-753.
162. Massie H.R., Ofosu-Appiah W., Aiello V.R. Elevated serum copper is associated with reduced immune response in aging mice. Gerontology. 39:1993;136-145.
163. Smith B.S.W., Wright H. Effect of dietary molybdenum and copper metabolism, evidence for the involvement of molybdenum in abnormal binding of copper to plasma proteins. Clin Chim Acta. 62:1975;55-60.
164. Faure G., Bene M.C., Tamisier J.N., Gaucher A., Dukeille J. Thymulin (FTS-Zn) induced in vitro modulation of T-cell subset markers on lymphocytes from arthritis and systemic lupus erythematosis patients. Int J Immunopharmacol. 6:1984;308-314.
165. Savino W., Dardenne M. Thymic hormone containing cells. VI. Immunohistologic evidence for the simultaneous presence of thymulin, thymopoietin and thymosin alpha 1 in normal and pathological thymuses. Eur J Immunol. 14:1984;987-991.
166. Vyas D., Chandra R.K. Thymic factor activity, lymphocyte stimulation response and antibody producing cells in copper deficiency. Nutr Res. 3:1983;343-349.
167. Bala S., Failla M.L. Copper repletion restores the number and function of CD4 cells in copper deficient rats. J Nutr. 123:1993;991-996.
168. Xin Z., Waterman D.F., Hemken R.W., Harmon R.J. Effects of copper status on neutrophil function, superoxidase dismutase and copper distribution in steers. J Dairy Sci. 74:1991;3078-3085.
169. Jones D.G., Suttle N.F. Some effects of copper deficiency on leucocyte function in sheep and cattle. Res Vet Sci. 31:1981;151-157.
170. Boyne R., Arthur J.R. Effects of selenium and copper deficiency on neutrophil function in cattle. J Comp Pathol. 91:1981;271-278.
171. Duell T., Lengfelder E., Fink R., Giesen R., Bauchinger M. Effects of activated oxygen species in human lymphocytes. Mutat Res. 336:1995;29-38.
172. O'Dell B.L. Interleukin-2 production is altered by copper deficiency. Nutr Rev. 51:1993;307-309.
173. Prohaska J.R., Lukasewycz O.A. Copper deficiency supresses the immune response in mice. Science. 213:1981;559-561.
174. Fujiwara Y., Kaji T., Yamamoto C., Sakamoto M., Kozuka H. Stimulatory effect of lead on the proliferation of cultured vascular smooth muscle cells. Toxicology. 98:1995;105-110.
175. Kaji T., Ohkawara S., Inada M., Yamamoto C., Sakamoto M., Kozuka H. Alteration of glycoaminoglycans induced by cadmium in cultured vascular smooth muscle cells. Arch Toxicol. 68:1994;560-565.
176. Jimi S., Saku K., Uesugi N., Sakata N., Takebayashi S. Oxidised low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells. Atherosclerosis. 116:1995;15-26.
177. Stait S.E., Fitzsimmons C.M., Bowyer D.E. The effect of low density lipoprotein on matrix turnover. J Vasc Res. 33(Suppl 1):1996;95.
178. Saari J.T. Dietary copper deficiency and endothelium-dependent relaxation of rat aorta. Proc Soc Exp Biol Med. 200:1992;19-24.
179. Schushke D.A., Reed M.W., Saari J.T., Miller F.N. Copper deficiency alters vasodilation in the rat cremaster muscle microcirculation. J Nutr. 122:1992;1547-1552.
180. Klevay L.M. Hypertension in rats due to copper deficiency. Nutr Rep Int. 35:1987;999-1005.
181. Abou-Shady E.A., Farrag H.E., El-Damarawy N.A., Mohamed F.A., Kamel A.M., Massoud A.A. In vitro effects of trace elements on blood clotting and platelet function. J Egypt Public Health Assoc. 66:1991;21-48.
182. Schuschke D.A., Saari J.T., Nuss J.W., Miller F.N. Platelet thrombus formation and hemostasis are delayed in the microcirculation of copper-deficient rats. J Nutr. 124:1994;1258-1264.
183. Lind S.E., McDonagh J.R., Smith C.J. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate. Blood. 82:1993;1522-1531.
184. Johnson W.T., Dufault S.N. Intracellular calcium mobilization in rat platelets is adversely affected by copper deficiency. Biochim Biophys Acta. 1175:1993;263-268.
185. Morin C.L., Allen K.G., Mathias M.M. Thromboxane production in copper-deficient and marginal platelets: influence of superoxide dismutase and lipid hydroperoxides. Proc Soc Exp Biol Med. 202:1993;167-173.
186. Schuschke L.A., Saari J.T., Miller F.N., Schushke D.A. Haemostatic mechanisms in marginally copper-deficient rats. J Lab Clin Med. 125:1995;748-753.
187. Kuivaniemi H., Peltonen L., Palotie A., Kaitila I., Kivirikko K.I. Abnormal copper metabolism and deficient lysyl oxidase activity in a heritable connective tissue disorder. J Clin Invest. 69:1982;730-733.
188. Siegal R.C. Lysyl oxidase. Int Rev Connect Tissue Res. 8:1979;73-118.
189. Reid G.M. Sudden infant death syndrome: congenital deficiency. Med Hypotheses. 24:1987;167-175.
190. Vlad M., Bordas E., Tomus R., Sava D., Farkas E., Uza G. Effect of copper sulfate on experimental atherosclerosis. Biol Trace Elem Res. 38:1993;47-54.
191. Pucheu S., Coudray C., Tresallet N., Favier A., deLeiris J. Effect of dietary antioxidant trace element supply on cardiac tolerance to ischemia-reperfusion in the rat. J Mol Cell Cardiol. 27:1995;2303-2314.
192. Petering H.G., Murthy L., Stemmer K.L., Finelli V.N., Menden E.E. Effects of copper deficiency on the cardiovascular system of the rat. The role of dietary sucrose and excessive zinc. Biol Trace Elem Res. 9:1986;251-270.
193. Coulson W.F., Carnes W.H. Cardiovascular studies on copper-deficient swine. II. Mechanical properties of the aorta. Lab Invest. 11:1963;1316-1321.
194. Shields G.S., Coulson W.F., Kimball D.A., Carnes W.H., Cartwright G.E., Wintrobe M.M. Studies on copper metabolism. XXXII. Cardiovascular lesions in copper-deficient swine. Am J Pathol. 41:1962;603-621.
195. Hunt C.E., Carlton W.W. Cardiovascular lesions associated with experimental copper deficiency in the rabbit. J Nutr. 87:1965;385-393.
196. Harman D. Effect of dietary copper on rabbit atherosclerosis. Circulation. 29-30(Suppl 3):1964;III-12.
197. Harman D. Atherogenesis in minipigs: effects of dietary fat unsaturation and of copper. Circulation. 37-38(Suppl 6):1968;VI-8.
198. Punsar S., Erametsa O., Karvonen M.J., Ryhanen A., Hilska P., Vornamo H. Coronary heart disease and drinking water. A search in two Finnish cohorts for evidence of a water factor. J Chronic Dis. 28:1975;259-287.
199. Salonen J.T., Salonen R., Korpela H., Suntionen S., Tuomilento J. Serum copper and the risk of acute myocardial infarction: a prospective population study in men in Eastern Finland. Am J Epidemiol. 134:1991;268-276.
200. Kok F.J., Van Duijn C.M., Hofman A.et al. Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am J Epidemiol. 128:1988;352-359.
201. Reunanen A., Knekt P., Aaron R-K. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol. 136:1992;1082-1090.
202. Manttari M., Manninen V., Huttunen J.K.et al. Serum ferritin and caeruloplasmin as coronary risk factors. Eur Heart J. 15:1994;1599-1603.
203. Nyyssönen K., Parviainen M.T., Salonen R., Tuomilehto J., Salonen J.T. Vitamin C deficiency and risk of myocardial infarction: prospective study of men from eastern Finland. Br Med J. 314:1997;634-638.
204. Jayakumari N., Ambikakumari V., Balakrishnan G., Subramonia Iyer K. Antioxidant status in relation to free radical production during stable and unstable anginal syndromes. Atherosclerosis. 94:1992;183-190.
205. Oster O., Dahm M., Oelert H. Element concentrations (selenium, copper, zinc, iron, magnesium, potassium, phosphorus) in heart tissue of patients with coronary heart disease correlate with physiological parameters of the heart. Eur Heart J. 14:1993;770-774.
206. Suciu A., Chirulescu Z., Zeana C., Pirvulescu R. Study of serum ceruloplasmin and the copper/zinc ratio in cardiovascular diseases. Romu J Intern Med. 30:1992;193-200.
207. Tan I.K., Chua K.S., Toh A.K. Serum magnesium, copper and zinc concentrations in acute myocardial infarction. J Clin Lab Anal. 6:1992;324-328.
208. Singh T.K. Serum ceruloplasmin in acute myocardial infarction. Acta Cardiol. 47:1992;321-329.
209. Jain V.K., Mohan G. Serum zinc and copper in myocardial infarction with particular reference to prognosis. Biol Trace Elem Res. 31:1991;317-322.
210. Mielcarz G., Patelski J., Uryszek W. Calcium, magnesium, copper and zinc in blood serum in men with femoral atherosclerosis. Rocz Panstw Zakl Hig. 46:1995;59-65.
211. Alfthan G., Pesonen E., Neuvonen P.J.et al. Relationship between myocardial macrominerals and trace elements and luminal narrowing of coronary arteries in Finnish children. J Trace Elem Electrolytes Health Dis. 6:1992;45-49.
212. Crockson R.A., Payne C.J., Ratcliff A.P., Soothill J.F. Time sequence of acute phase reactive proteins following surgical trauma. Clin Chim Acta. 14:1966;435-441.
213. Mori T., Sasaki J., Kawaguchi H.et al. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J. 129:1995;234-238.
214. Vlad M., Caseanu E., Uza G., Petrescu M. Concentration of copper, zinc, chromium, iron and nickel in the abdominal aorta of patients deceased with coronary heart disease. J Trace Elem Electrolytes Health Dis. 8:1994;111-114.
215. Jaakkola P., Hippelainen M., Kantola M. Copper and zinc concentrations of abdominal aorta and liver in patients with infra renal abdominal aortic aneurysm or aortoiliacal occlusive disease. Ann Chir Gynaecol. 83:1994;304-308.
216. Dembinska-Kiec A., Zmuda A., Bieron K.et al. Plasma antioxidant potency and serum copper levels in atherosclerosis. Pol J Pharmacol Pharm. 37:1985;123-132.
217. Chen M.D., Lin P.Y., Tsou C.T., Wang J.J., Lin W.H. Selected metals status in patients with non-insulin-dependent diabetes mellitus. Biol Trace Elem Res. 50:1995;119-124.
218. Williams N.R., Rajput-Williams J., West J.A., Nigdikar S.V., Foote J.W., Howard A.N. Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus. Analyst. 120:1995;887-890.
219. Zbronska H., Greszczak W., Jendryczko A., Zbronski R., Kuzniewicz R. Activity of superoxide dismutase in erythrocytes and leukocytes and levels of zinc and copper in blood of patients with diabetes. Effect of diabetic treatment on examined parameters. Pol Arch Med Wewn. 94:1995;228-234.